Danyang Baitao Optical Glasses Co., Ltd. – Trademark Portfolio

Entity Type: 99

Danyang Baitao Optical Glasses Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include GLEASANNA. The owner is based in Danyang.

Baolitu Science and Technology Park

Danyang 212300 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GLEASANNA
GLEASANNA
Registered 2023

Trademark Classifications

Danyang Baitao Optical Glasses Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Danyang Baitao Optical Glasses Co., Ltd. have?

Danyang Baitao Optical Glasses Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Danyang Baitao Optical Glasses Co., Ltd. file in?

Danyang Baitao Optical Glasses Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Danyang Baitao Optical Glasses Co., Ltd.'s most well-known trademarks?

Danyang Baitao Optical Glasses Co., Ltd.'s registered trademark portfolio includes well-known marks such as GLEASANNA. These are among 1 currently registered trademark in the portfolio.

What is Danyang Baitao Optical Glasses Co., Ltd.'s trademark registration success rate?

Danyang Baitao Optical Glasses Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.